Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/504
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | HEATON, Joanne H. | - |
dc.contributor.author | WOOD, Michelle A. | - |
dc.contributor.author | KIM, Alex C. | - |
dc.contributor.author | LIMA, Lorena O. | - |
dc.contributor.author | BARLASKAR, Ferdous M. | - |
dc.contributor.author | ALMEIDA, Madson Q. | - |
dc.contributor.author | FRAGOSO, Maria C. B. V. | - |
dc.contributor.author | KUICK, Rork | - |
dc.contributor.author | LERARIO, Antonio M. | - |
dc.contributor.author | SIMON, Derek P. | - |
dc.contributor.author | SOARES, Ibere C. | - |
dc.contributor.author | STARNES, Elisabeth | - |
dc.contributor.author | THOMAS, Dafydd G. | - |
dc.contributor.author | LATRONICO, Ana C. | - |
dc.contributor.author | GIORDANO, Thomas J. | - |
dc.contributor.author | HAMMER, Gary D. | - |
dc.date.accessioned | 2013-07-30T14:41:58Z | - |
dc.date.available | 2013-07-30T14:41:58Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | AMERICAN JOURNAL OF PATHOLOGY, v.181, n.3, p.1017-1033, 2012 | - |
dc.identifier.issn | 0002-9440 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/504 | - |
dc.description.abstract | Dysregulation of the WNT and insulin-like growth factor 2 (IGF2) signaling pathways has been implicated in sporadic and syndromic forms of adrenocortical carcinoma (ACC). Abnormal beta-catenin staining and CTNNB1 mutations are reported to be common in both adrenocortical adenoma and ACC, whereas elevated IGF2 expression is associated primarily with ACC. To better understand the contribution of these pathways in the tumorigenesis of ACC, we examined clinicopathological and molecular data and used mouse models. Evaluation of adrenal tumors from 118 adult patients demonstrated an increase in CTNNB1 mutations and abnormal beta-catenin accumulation in both adrenocortical adenoma and ACC. In ACC, these features were adversely associated with survival. Mice with stabilized beta-catenin exhibited a temporal progression of increased adrenocortical hyperplasia, with subsequent microscopic and macroscopic adenoma formation. Elevated Igf2 expression alone did not cause hyperplasia. With the combination of stabilized beta-catenin and elevated Igf2 expression, adrenal glands were larger, displayed earlier onset of hyperplasia, and developed more frequent macroscopic adenomas (as well as one carcinoma). Our results are consistent with a model in which dysregulation of one pathway may result in adrenal hyperplasia, but accumulation of a second or multiple alterations is necessary for tumorigenesis. (Ant J Pathol 2012, 181:1017-1033; http://dx.doi.org/10.1016/j.ajpath.2012.05.026) | - |
dc.description.sponsorship | University of Michigan | - |
dc.description.sponsorship | National Institutes of Health (NIH) [DK062027, CA134606, T32 DK07245, T32 HD007505, T32-CA009676] | - |
dc.description.sponsorship | National Council for Scientific and Technological Development of Brazil [CNPq 300209/2008-8] | - |
dc.description.sponsorship | Coordination for Improvement of Higher Education (CAPES), Brazil | - |
dc.language.iso | eng | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.ispartof | American Journal of Pathology | - |
dc.rights | restrictedAccess | - |
dc.subject.other | familial adenomatous polyposis | - |
dc.subject.other | beckwith-wiedemann-syndrome | - |
dc.subject.other | factor-ii | - |
dc.subject.other | expression profiles | - |
dc.subject.other | molecular markers | - |
dc.subject.other | transgenic mice | - |
dc.subject.other | adrenal masses | - |
dc.subject.other | tumor-origin | - |
dc.subject.other | mouse model | - |
dc.subject.other | gene | - |
dc.title | Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and beta-Catenin | - |
dc.type | article | - |
dc.rights.holder | Copyright ELSEVIER SCIENCE INC | - |
dc.identifier.doi | 10.1016/j.ajpath.2012.05.026 | - |
dc.identifier.pmid | 22800756 | - |
dc.subject.wos | Pathology | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | HEATON, Joanne H.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | WOOD, Michelle A.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | KIM, Alex C.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | BARLASKAR, Ferdous M.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | KUICK, Rork:Univ Michigan, Univ Michigan Canc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | SIMON, Derek P.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | STARNES, Elisabeth:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | THOMAS, Dafydd G.:Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | GIORDANO, Thomas J.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Univ Michigan Canc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA | - |
hcfmusp.author.external | HAMMER, Gary D.:Univ Michigan, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Univ Michigan Canc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA | - |
hcfmusp.description.beginpage | 1017 | - |
hcfmusp.description.endpage | 1033 | - |
hcfmusp.description.issue | 3 | - |
hcfmusp.description.volume | 181 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000309251100029 | - |
hcfmusp.origem.id | 2-s2.0-84865260495 | - |
hcfmusp.publisher.city | NEW YORK | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Allolio B, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P31 | - |
hcfmusp.relation.reference | Almeida MQ, 2010, J CLIN ENDOCR METAB, V95, P1458, DOI 10.1210/jc.2009-2040 | - |
hcfmusp.relation.reference | Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065 | - |
hcfmusp.relation.reference | Anderson MR, 2006, CLIN CANCER RES, V12, P5936, DOI 10.1158/1078-0432.CCR-06-1208 | - |
hcfmusp.relation.reference | Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887 | - |
hcfmusp.relation.reference | Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820 | - |
hcfmusp.relation.reference | Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb | - |
hcfmusp.relation.reference | Bernard MH, 2003, J CLIN ENDOCR METAB, V88, P998, DOI 10.1210/jc.2002-021117 | - |
hcfmusp.relation.reference | Bertherat J, 2009, BEST PRACT RES CL EN, V23, P261, DOI 10.1016/j.beem.2008.10.006 | - |
hcfmusp.relation.reference | Bertherat J, 2006, NAT CLIN PRACT ENDOC, V2, P632, DOI 10.1038/ncpendmet0321 | - |
hcfmusp.relation.reference | Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029 | - |
hcfmusp.relation.reference | Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886 | - |
hcfmusp.relation.reference | Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231 | - |
hcfmusp.relation.reference | Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885 | - |
hcfmusp.relation.reference | BOOKOUT A.L., 2006, CURR PROTOC MOL BIOL | - |
hcfmusp.relation.reference | Boulkroun S, 2011, ENDOCRINOLOGY, V152, P4753, DOI 10.1210/en.2011-1205 | - |
hcfmusp.relation.reference | Brault V, 2001, DEVELOPMENT, V128, P1253 | - |
hcfmusp.relation.reference | Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115 | - |
hcfmusp.relation.reference | DeBaun M, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P227 | - |
hcfmusp.relation.reference | de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075 | - |
hcfmusp.relation.reference | Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342 | - |
hcfmusp.relation.reference | Else T, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P153 | - |
hcfmusp.relation.reference | Fassnacht M, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P23 | - |
hcfmusp.relation.reference | Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190 | - |
hcfmusp.relation.reference | Fottner C, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P235 | - |
hcfmusp.relation.reference | Gaujoux S, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P263 | - |
hcfmusp.relation.reference | Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006 | - |
hcfmusp.relation.reference | Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559 | - |
hcfmusp.relation.reference | Gicquel C, 2001, CANCER RES, V61, P6762 | - |
hcfmusp.relation.reference | Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067 | - |
hcfmusp.relation.reference | Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1 | - |
hcfmusp.relation.reference | Giordano TJ, 2011, AM J SURG PATHOL, V35, P471, DOI 10.1097/PAS.0b013e31820bcf21 | - |
hcfmusp.relation.reference | Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379 | - |
hcfmusp.relation.reference | Heaton JH, 2011, ADRENOCORTICAL CARCINOMA: BASIC SCIENCE AND CLINICAL CONCEPTS, P285 | - |
hcfmusp.relation.reference | Hershkovitz L, 2007, ENDOCRINOLOGY, V148, P976, DOI 10.1210/en.2006-1100 | - |
hcfmusp.relation.reference | Huang CCJ, 2010, ENDOCRINOLOGY, V151, P1119, DOI 10.1210/en.2009-0814 | - |
hcfmusp.relation.reference | Kawabe K, 1999, MOL ENDOCRINOL, V13, P1267, DOI 10.1210/me.13.8.1267 | - |
hcfmusp.relation.reference | Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039 | - |
hcfmusp.relation.reference | Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493 | - |
hcfmusp.relation.reference | King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106 | - |
hcfmusp.relation.reference | Kirschner LS, 2006, J CLIN ENDOCR METAB, V91, P14, DOI 10.1210/jc.2005-1739 | - |
hcfmusp.relation.reference | Kirschner LS, 2002, ANN NY ACAD SCI, V968, P222 | - |
hcfmusp.relation.reference | Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389 | - |
hcfmusp.relation.reference | Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085 | - |
hcfmusp.relation.reference | Libe R, 2009, J CLIN ENDOCR METAB, V94, P3631, DOI 10.1210/jc.2009-1025 | - |
hcfmusp.relation.reference | Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130 | - |
hcfmusp.relation.reference | Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402 | - |
hcfmusp.relation.reference | Marchesa P, 1997, DIS COLON RECTUM, V40, P1023, DOI 10.1007/BF02050923 | - |
hcfmusp.relation.reference | Masi G, 2009, J ENDOCRINOL INVEST, V32, P597, DOI 10.3275/6294 | - |
hcfmusp.relation.reference | Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362 | - |
hcfmusp.relation.reference | Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-0457 | - |
hcfmusp.relation.reference | ONO C, 1991, JPN J SURG, V21, P234, DOI 10.1007/BF02470915 | - |
hcfmusp.relation.reference | Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724 | - |
hcfmusp.relation.reference | Previdi S, 2010, EUR J CANCER, V46, P1679, DOI 10.1016/j.ejca.2010.02.036 | - |
hcfmusp.relation.reference | Purcell R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-96 | - |
hcfmusp.relation.reference | Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080 | - |
hcfmusp.relation.reference | Scheys JO, 2011, ENDOCRINOLOGY, V152, P3430, DOI 10.1210/en.2010-0986 | - |
hcfmusp.relation.reference | Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120 | - |
hcfmusp.relation.reference | Smith TGPJ, 2000, DIS COLON RECTUM, V43, P1739 | - |
hcfmusp.relation.reference | Soon PSH, 2008, ONCOLOGIST, V13, P548, DOI 10.1634/theoncologist.2007-0243 | - |
hcfmusp.relation.reference | Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102 | - |
hcfmusp.relation.reference | Sun FL, 1997, NATURE, V389, P809 | - |
hcfmusp.relation.reference | Tadjine M, 2008, CLIN ENDOCRINOL, V68, P264, DOI 10.1111/j.1365-2265.2007.03033.x | - |
hcfmusp.relation.reference | Tadjine M, 2008, CLIN ENDOCRINOL, V69, P367, DOI 10.1111/j.1365-2265.2008.03273.x | - |
hcfmusp.relation.reference | Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006 | - |
hcfmusp.relation.reference | Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593 | - |
hcfmusp.relation.reference | Trezzi R, 2009, INT J SURG PATHOL, V17, P343, DOI 10.1177/1066896909335155 | - |
hcfmusp.relation.reference | Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031 | - |
hcfmusp.relation.reference | Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108 | - |
hcfmusp.relation.reference | Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456 | - |
hcfmusp.relation.reference | Weber MM, 1999, ENDOCRINOLOGY, V140, P1537, DOI 10.1210/en.140.4.1537 | - |
hcfmusp.relation.reference | WEISS DW, 1984, CANCER IMMUNOL IMMUN, V18, P1 | - |
hcfmusp.relation.reference | WEISS DW, 1984, TRANSPLANT P, V16, P528 | - |
hcfmusp.relation.reference | West AN, 2007, CANCER RES, V67, P600, DOI 10.1158/0008-5472.CAN-06-3767 | - |
hcfmusp.relation.reference | WOLF E, 1994, ENDOCRINOLOGY, V135, P1877, DOI 10.1210/en.135.5.1877 | - |
hcfmusp.relation.reference | Wood MA, 2011, MOL CELL ENDOCRINOL, V336, P206, DOI 10.1016/j.mce.2010.11.012 | - |
hcfmusp.relation.reference | Woodson K, 2004, J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042 | - |
hcfmusp.relation.reference | Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443 | - |
dc.description.index | MEDLINE | - |
hcfmusp.remissive.sponsorship | CAPES | - |
hcfmusp.remissive.sponsorship | CNPq | - |
hcfmusp.remissive.sponsorship | NIH | - |
hcfmusp.lim.ref | 2012 | - |
hcfmusp.citation.scopus | 143 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/14 Artigos e Materiais de Revistas Científicas - LIM/42 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_LIMA_Progression_to_Adrenocortical_Tumorigenesis_in_Mice_and_Humans_2012.PDF Restricted Access | publishedVersion (English) | 2.81 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.